Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
2022 · Journal for ImmunoTherapy of Cancer · 73 citations
https://doi.org/10.1136/jitc-2021-003982